BR112015000494A2 - matriz e composições da camada para a proteção dos biotivos - Google Patents

matriz e composições da camada para a proteção dos biotivos

Info

Publication number
BR112015000494A2
BR112015000494A2 BR112015000494A BR112015000494A BR112015000494A2 BR 112015000494 A2 BR112015000494 A2 BR 112015000494A2 BR 112015000494 A BR112015000494 A BR 112015000494A BR 112015000494 A BR112015000494 A BR 112015000494A BR 112015000494 A2 BR112015000494 A2 BR 112015000494A2
Authority
BR
Brazil
Prior art keywords
matrix
layer compositions
protection
biotives
bioactive
Prior art date
Application number
BR112015000494A
Other languages
English (en)
Inventor
Arhancet Graciela
A Hume John
J Fischer Matthew
Karnati Rangarani
Houston Smith Stephen
Wang Xiaojun
Original Assignee
Novus Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novus Int Inc filed Critical Novus Int Inc
Publication of BR112015000494A2 publication Critical patent/BR112015000494A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A23K40/35—Making capsules specially adapted for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
    • A23L29/272—Gellan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
    • A23P20/10—Coating with edible coatings, e.g. with oils or fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Laminated Bodies (AREA)

Abstract

abstract the invention relates to matrix and layer compositions comprising a first polymer. the matrix and layer compositions are useful in the delivery of bioactives. in particular, the matrices and layers may have advantageous properties including mechanical properties and protection of bioactives and may also provide for ph-dependent release of a bioactive. ---------------------------------------------------------------------------------------------------------- tradução do resumo resumo patente de invenção: "matriz e composições da camada para a proteção dos biotivos". a presente invenção refere-se à matriz e as composições da camada compreendendo um primeiro polímero. a matriz e as composições da camada são úteis na liberação dos bioativos. em particular, as matrizes e as camadas podem ter as propriedades vantajosas incluindo as propriedades mecânicas e a proteção dos bioativos e também podem fornecer a liberação dependente do ph de um bioativo.
BR112015000494A 2012-07-12 2013-07-11 matriz e composições da camada para a proteção dos biotivos BR112015000494A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261670817P 2012-07-12 2012-07-12
PCT/US2013/050051 WO2014011857A1 (en) 2012-07-12 2013-07-11 Matrix and layer compositions for protection of bioactives

Publications (1)

Publication Number Publication Date
BR112015000494A2 true BR112015000494A2 (pt) 2017-06-27

Family

ID=49916546

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015000494A BR112015000494A2 (pt) 2012-07-12 2013-07-11 matriz e composições da camada para a proteção dos biotivos

Country Status (11)

Country Link
US (3) US9452143B2 (pt)
EP (2) EP2871973B1 (pt)
CN (2) CN107753462B (pt)
AU (2) AU2013290122B2 (pt)
BR (1) BR112015000494A2 (pt)
CA (1) CA2878617A1 (pt)
ES (1) ES2703051T3 (pt)
HK (1) HK1257735A1 (pt)
MX (1) MX2015000395A (pt)
PL (1) PL2871973T3 (pt)
WO (1) WO2014011857A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS57845B1 (sr) 2012-02-09 2018-12-31 Novus Int Inc Ciklični dimeri koji sadrže heteroatom
ES2703051T3 (es) 2012-07-12 2019-03-06 Novus Int Inc Composiciones de matriz y de capa para la protección de agentes bioactivos
CN105942008A (zh) * 2016-07-26 2016-09-21 云南爱尔发生物技术股份有限公司 一种营养强化的含天然虾红素的鹌鹑饲料
CN107006694B (zh) * 2017-03-20 2019-03-01 刘春海 一种肉牛、肉羊用植物精油组合物、制备方法及其应用
US12082595B2 (en) 2017-09-28 2024-09-10 Evonik Operations Gmbh Rumen protected products
WO2019209261A1 (en) * 2018-04-24 2019-10-31 Novus International Inc. Protected compositions comprising two coating layers
US11730708B2 (en) 2019-12-11 2023-08-22 Evonik Operations Gmbh Dosage form for use in treating or preventing of a disease
BR112022011130A2 (pt) * 2019-12-11 2022-08-23 Evonik Operations Gmbh Forma de dosagem compreendendo um agente alcalino e uma camada de revestimento entérica
CN112998133B (zh) 2021-02-24 2022-08-23 中国科学院上海药物研究所 一种植物精油氨基酸组合物及其制备方法
GB2627641A (en) * 2021-12-08 2024-08-28 Nutramax Lab Inc Supplemental coating and related method
EP4444291A1 (en) * 2021-12-08 2024-10-16 Nutramax Laboratories, Inc. Supplemental coating and related method

Family Cites Families (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2703316A (en) 1951-06-05 1955-03-01 Du Pont Polymers of high melting lactide
US2787595A (en) 1955-07-11 1957-04-02 Union Oil Co Sulfoxide containing detergent compositions
US3290254A (en) 1961-10-25 1966-12-06 Chevron Res Methyl-beta-hydroxydodecyl sulfoxide containing detergent compositions
US3329617A (en) 1962-11-14 1967-07-04 Procter & Gamble Sulfoxide detergent
US3272860A (en) 1964-04-02 1966-09-13 Monsanto Co Preparation of methionine analogues
US3288860A (en) 1965-03-30 1966-11-29 Procter & Gamble Alkali metal salts of sulfinyl carbanions and alkali metal alkanesulfenates, processes for their preparation and reactions thereof with alkyl halides
US3761518A (en) 1971-03-12 1973-09-25 Du Pont 2-hydroxy-4-methylsulfinyl-butyric acid and derivatives
US3773927A (en) 1971-12-20 1973-11-20 Du Pont Preparation of an aqueous slurry of ammonium chloride and methylmercapto-hydroxybutyric acid
US4033938A (en) 1974-01-21 1977-07-05 American Cyanamid Company Polymers of unsymmetrically substituted 1,4-dioxane-2,5-diones
US4095029A (en) 1977-01-17 1978-06-13 Standard Oil Company (Indiana) 2-hydroxy-3-alkylsulfoxypropyl-1 esters of arene polycarboxylic acids
US4235942A (en) 1979-02-22 1980-11-25 Standard Oil Company (Indiana) Digestible polyamino acids
US4451486A (en) 1979-09-04 1984-05-29 Monsanto Company Animal feed supplement having reduced corrosion characteristics
US4317779A (en) 1980-08-21 1982-03-02 The Procter & Gamble Company Alpha-sulfoxide and alpha-sulfone carboxyl compounds
US4395363A (en) 1980-08-21 1983-07-26 The Procter & Gamble Company Alpha-sulfoxide and alpha-sulfone carboxyl compounds
US4310690A (en) 1980-10-08 1982-01-12 E. I. Du Pont De Nemours And Company Preparation of the calcium salt of α-hydroxy-gamma-methylmercaptobutyric acid
US4353942A (en) 1980-11-17 1982-10-12 Dayco Corporation Coating method
US4419198A (en) 1981-06-22 1983-12-06 Monsanto Company Purification of methioine hydroxy analogue hydrolyzate by electrodialysis
US4388327A (en) 1981-10-30 1983-06-14 E. I. Du Pont De Nemours & Co. Method of increasing milk production of dairy cattle
US4435527A (en) 1983-01-24 1984-03-06 Texaco Inc. Polyester polymer polyols made with polyester polycarbonates and polyurethanes therefrom
US4855495A (en) 1983-09-06 1989-08-08 Monsanto Company Enhanced 2-hydroxy-4-methylthiobutanoic acid composition and method of preparation
US4524077A (en) 1983-11-14 1985-06-18 Monsanto Company Liquid 2-hydroxy-4-methylthiobutyric acid and process for the preparation thereof
US4579962A (en) 1984-02-24 1986-04-01 Monsanto Company Enhanced 2-hydroxy-4-methylthiobutanoic acid compositions and method of preparation
FR2575753B1 (fr) 1985-01-07 1987-02-20 Adir Nouveaux derives peptidiques a structure polycyclique azotee, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US4727163A (en) 1985-07-11 1988-02-23 E. I. Du Pont De Nemours And Company Process for preparing highly pure cyclic esters
US4883911A (en) 1986-05-08 1989-11-28 Monsanto Company Process for the preparation of alkylthioalkanoate salts
US4777289A (en) 1986-05-08 1988-10-11 Monsanto Company Process for the preparation of alkylthioalkanoate salts
US4835293A (en) 1987-02-24 1989-05-30 E. I. Du Pont De Nemours And Company Atmospheric pressure process for preparing pure cyclic esters
ATE160360T1 (de) 1989-07-18 1997-12-15 Biosearch Italia Spa Aus dalbaheptide hergestellte pentapeptid- antibiotika
US5294605A (en) 1990-07-19 1994-03-15 The Scripps Research Institute Amphiphilic peptide compositions and analogues thereof
US5326887A (en) 1991-02-27 1994-07-05 E. I. Du Pont De Nemours And Company Process for the preparation of 1,4-dioxane-2,5-diones
US5254718A (en) 1991-02-27 1993-10-19 E. I. Du Pont De Nemours & Company Esters of unsymmetrically 2-substituted glycolic acid dimers
US5142023A (en) 1992-01-24 1992-08-25 Cargill, Incorporated Continuous process for manufacture of lactide polymers with controlled optical purity
US5352461A (en) 1992-03-11 1994-10-04 Pharmaceutical Discovery Corporation Self assembling diketopiperazine drug delivery system
US5420304A (en) 1992-03-19 1995-05-30 Biopak Technology, Ltd. Method to produce cyclic esters
DE4221711A1 (de) 1992-07-02 1994-01-05 Bayer Ag Optisch aktive Aminosäuresulfoxid- und sulfon-Derivate, ihre Herstellung, ihre Polymerisation und Verwendung als Adsorbentien für die chromatographische Racematspaltung
US5399665A (en) 1992-11-05 1995-03-21 Massachusetts Institute Of Technology Biodegradable polymers for cell transplantation
US5310599A (en) 1993-05-06 1994-05-10 E. I. Du Pont De Nemours And Company Method for making polymers of alpha-hydroxy acids
US6428771B1 (en) 1995-05-15 2002-08-06 Pharmaceutical Discovery Corporation Method for drug delivery to the pulmonary system
US6727285B1 (en) 1995-11-07 2004-04-27 George M. Haik, Jr. Use of D-arginine and/or L-arginine to protect the amino groups of biological substances from damage, inactivation, or modification by toxic carbonyls and/or dicarbonyls
IT1282402B1 (it) 1996-05-03 1998-03-20 Condea Augusta Spa Composizioni acquose di tensioattivi ad elevata viscosita'
ATE264318T1 (de) 1996-11-19 2004-04-15 Amgen Inc Aryl und heteroaryl substituierte kondensierte pyrrole als entzündunghemmende mittel
US5973200A (en) 1997-01-23 1999-10-26 Novus International, Inc. Process for the preparation of 2-hydroxy-4-(methylthio) butanoic acid or methionine by mercaptan addition
AU7575298A (en) 1997-05-14 1998-12-08 Redox, Inc. Use of d-arginine and/or l-arginine to protect the amino groups of biological substances from damage, inactivation, or modification by toxic carbonyls and/or dicarbonyls
US6017563A (en) * 1997-07-25 2000-01-25 Novus International, Inc. Process for optimizing milk production
MA26659A1 (fr) 1998-08-06 2004-12-20 Pfizer Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
USRE39403E1 (en) * 1998-11-13 2006-11-14 Adisseo Ireland Limited Method for supplying bioavailable methionine to a cow
FR2785773B1 (fr) * 1998-11-13 2001-04-20 Rhone Poulenc Nutrition Animal Utilisation d'esters de methionine en nutrition animale
AU4054900A (en) 1999-04-02 2000-10-23 Advanced Medicine East, Inc. Desleucyl glycopeptide antibiotics and methods of making same
US6939693B2 (en) * 1999-10-29 2005-09-06 Novus International, Inc. Enantioselective oligomerization of α-hydroxy carboxylic acids and α-amino acids
US6469133B2 (en) 1999-12-13 2002-10-22 Board Of Trustees Of Michigan State University Process for the preparation of polymers of dimeric cyclic esters
DE10000333A1 (de) 2000-01-07 2001-07-19 Lohmann Therapie Syst Lts Pharmazeutische Zusammensetzung zur transdermalen Verabreichung von Hormonen mit einem permeationsverbessernden Zusatzstoff
AU2002259100A1 (en) * 2001-05-02 2002-11-11 Novus International, Inc. Enantioselective oligomerization of alpha-hydroxy carboxylic acids and alpha-amino acids
WO2003010157A1 (en) 2001-07-23 2003-02-06 Dr. Reddy's Research Foundation Dioxane derivatives and a process for their preparation
US20030143366A1 (en) 2002-01-17 2003-07-31 Jerry Foley Polymeric and fibrous laminate and methods of forming and using same
EP1348516B1 (en) 2002-03-22 2006-02-01 Filtra-Systems Company Apparatus and method for recirculating machine tool coolant and removing ferrous debris therefrom
CN1448393A (zh) 2002-03-28 2003-10-15 拜尔公司 抗内寄生物用的新型二氧代吗啉
MXPA05009504A (es) 2003-03-07 2005-10-18 Warner Lambert Co Derivados de (-aminoacidos sustituidos con tetrazol y oxadiazolona.
DE602004016161D1 (de) 2003-07-07 2008-10-09 Nof Corp Triblock-copolymer, herstellungsverfahren dafür und biokompatibles material
RU2249029C1 (ru) 2003-07-23 2005-03-27 Петраков Александр Дмитриевич Способ получения водоугольного топлива и технологическая линия для его осуществления
JP4560304B2 (ja) 2004-02-18 2010-10-13 学校法人東海大学 側鎖にアミノエチル基を有するオリゴ乳酸エステル
JP4445769B2 (ja) 2004-02-18 2010-04-07 学校法人東海大学 側鎖にヒドロキシルエチル基を有するオリゴ乳酸エステル
WO2005077882A1 (ja) 2004-02-18 2005-08-25 Tokai Education Instruments Co., Ltd. 側鎖に置換基を有するオリゴ乳酸エステル
US8685435B2 (en) 2004-04-30 2014-04-01 Allergan, Inc. Extended release biodegradable ocular implants
FR2873376B1 (fr) 2004-07-23 2006-11-24 Tetrahedron Sas Nouveaux seleno-hydroxyacides et leurs derives, applications en nutrition, cosmetique et pharmacie
US20070053866A1 (en) 2005-09-06 2007-03-08 Novus International Inc. In-can and dry coating antimicrobial compositions having hydroxy analogs of methionine and derivatives
US20070231377A1 (en) * 2006-03-28 2007-10-04 Novus International Inc. Compositions for promoting hair growth
US20070231437A1 (en) 2006-03-30 2007-10-04 Novus International, Inc. Dry milling process for the production of ethanol and feed with highly digestible protein
CN100428964C (zh) 2006-06-29 2008-10-29 武汉理工大学 RGD多肽接枝聚(羟基乙酸-L-赖氨酸-L-乳酸)/β-磷酸三钙复合材料及其制备方法
CA2656697C (en) 2006-07-06 2012-12-04 Stepan Company Alkyl lactyllactates and processes of making the same
WO2008011272A2 (en) 2006-07-21 2008-01-24 Novus International Inc. Liquid monophasic lipid-soluble antioxidant compositions and processes for making the compositions
CA2659875C (en) 2006-08-04 2015-01-27 Manus Pharmaceuticals (Canada) Ltd. Multifunctional bioactive compounds
CA2693918A1 (en) * 2006-11-17 2008-05-22 Felipe Navarro Matrix-embedded compositions having organic acids and fatty acids
US20080119552A1 (en) * 2006-11-17 2008-05-22 Novus International Inc. Matrix-embedded compositions having organic acids and fatty acids
JP2008239601A (ja) 2007-02-26 2008-10-09 Sumitomo Chemical Co Ltd ラクチド化合物の製造方法
WO2009088879A1 (en) * 2008-01-04 2009-07-16 Novus International Inc. Combinations to improve animal health and performance
WO2009127009A1 (en) 2008-04-18 2009-10-22 Commonwealth Scientific And Industrial Research Organisation Condensation polymers
EP2151457A1 (en) 2008-07-28 2010-02-10 Total Petrochemicals France Process to make a diblock copolymer having a monovinylaromatic polymer block
JP2010111664A (ja) * 2008-10-10 2010-05-20 Sumitomo Chemical Co Ltd ２−ヒドロキシ−４−メチルチオブタン酸の製造方法
DE102008042932A1 (de) 2008-10-17 2010-04-22 Evonik Degussa Gmbh Herstellung und Verwendung von Methionylmethionin als Futtermitteladditiv für Fische und Krustentiere
SI3133160T1 (sl) 2008-10-24 2019-05-31 Sarepta Therapeutics, Inc. Sestavki, ki preskakujejo ekson za DMD
FR2942800B1 (fr) 2009-03-06 2012-04-20 Minasolve Procede de polymerisation par voie catalytique de 1,4-dioxanes-2,5 diones et les polymeres correspondants
JP2013503934A (ja) 2009-09-02 2013-02-04 エルジー・ケム・リミテッド 有機スズ化合物、その製造方法およびそれを用いたポリラクチドの製造方法
US8753621B2 (en) 2009-09-18 2014-06-17 Protherics Salt Lake City, Inc. BAB triblock polymers having improved release characteristics
JP2013514977A (ja) 2009-12-16 2013-05-02 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド 複数の物質の送達のための粒子
US8399686B2 (en) 2009-12-21 2013-03-19 Evonik Degussa Corporation Process for preparing cyclic esters comprising unsaturated functional groups and polyesters prepared from same
DE102010029399A1 (de) 2010-05-27 2011-12-01 Evonik Degussa Gmbh Cyclische Dipeptide als Futtermitteladditive
US20120128616A1 (en) 2010-11-19 2012-05-24 Voisin Sebastien Cosmetic composition comprising at least one elastomeric polyurethane and at least one cationic polymer
RS57845B1 (sr) 2012-02-09 2018-12-31 Novus Int Inc Ciklični dimeri koji sadrže heteroatom
ES2703051T3 (es) 2012-07-12 2019-03-06 Novus Int Inc Composiciones de matriz y de capa para la protección de agentes bioactivos

Also Published As

Publication number Publication date
US9452143B2 (en) 2016-09-27
PL2871973T3 (pl) 2019-02-28
CN104754956A (zh) 2015-07-01
EP3388056A1 (en) 2018-10-17
HK1257735A1 (zh) 2019-10-25
AU2016247230A1 (en) 2016-11-10
US20150157577A1 (en) 2015-06-11
CN107753462B (zh) 2021-01-08
CN107753462A (zh) 2018-03-06
AU2013290122A1 (en) 2015-01-29
CA2878617A1 (en) 2014-01-16
US10010506B2 (en) 2018-07-03
ES2703051T3 (es) 2019-03-06
MX2015000395A (es) 2015-04-10
US20170216208A1 (en) 2017-08-03
CN104754956B (zh) 2017-11-17
EP2871973A1 (en) 2015-05-20
WO2014011857A1 (en) 2014-01-16
EP2871973A4 (en) 2015-12-23
EP2871973B1 (en) 2018-10-03
AU2013290122B2 (en) 2016-08-11
US20160228391A1 (en) 2016-08-11
US9655863B2 (en) 2017-05-23
AU2016247230B2 (en) 2017-11-23

Similar Documents

Publication Publication Date Title
BR112015000494A2 (pt) matriz e composições da camada para a proteção dos biotivos
BR112015000320A2 (pt) composições farmacêuticas dissuasivas de abuso, de liberação prolongada
CR20150326A (es) Inhibidores de autotaxina
BR112015012547A2 (pt) composições de prostaciclina e métodos de sua utilização
BR112012029517A2 (pt) formulações de fragrância, métodos de fabricação e artigos compreendendo as mesmas.
BR112015022191A2 (pt) compostos heteroarila, seu uso e composição que os compreende
GT201400012A (es) Compuesto inhibidor de la señalizacion de la trayectoria notch
GT201200334A (es) Morfolinopirimidinas y su uso en terapia
ECSP12012318A (es) Inhibidores de pirazolil quinazolina cinasa
AR090465A1 (es) Formas solidas de un profarmaco de nucleotidos de tiofosforamidato
IL232113A (en) Boron-containing compounds, pharmaceuticals containing them and their use in inhibiting arginase
CL2008000789A1 (es) Compuestos derivados de adenina; composicion farmaceutica que comprende a dichos compuestos, utiles para tratar enfermedades alergicas, virales o cancer, entre otras.
BRPI0916286B8 (pt) amidofenóxi-indazóis úteis como inibidores de c-met, seus usos, e composição farmacêutica
BR112014013108A2 (pt) compostos tricíclicos fundidos como inibidores da quinase raf
BR112013032774A2 (pt) métodos para tratar e prevenir infecções por staphylococcus aureus e condições associadas
BR112014010290A2 (pt) composição farmacêutica, métodos, composições e usos
BR112015014438A2 (pt) composto, composição farmacêutica e uso de um composto
BR112013019628B8 (pt) conjugados de peg-carboidrato-lipídeo
BRPI1009663A2 (pt) "método para elevação dos níveis plaquetários em um indivíduo com essa necessidade, método de inibição de hemorragia em um indivíduo que a necessite e composição farmacêutica"
WO2012095752A3 (en) Personal care compositions
BR112015011430A2 (pt) composição para liberação imediata e prolongada
BR112013023984A2 (pt) derivados triazolil piperazina e triazolil piperidina substituidos como moduladores de gama secretase
WO2015066426A3 (en) Angiopoietin-based interventions for treating cerebral malaria
CO6470899A2 (es) 2,4-diaminopirimidinas para el tratamiento de enfermedades caracterizadas por proliferación celular excesiva o normal
BR112015001313A2 (pt) composições de vacina

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]